Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Currently, there are no pharmacological treatments for liver fibrosis related to non-alcoholic steatohepatitis.
Researchers believe this genetic mutation protected against the 14th century-bubonic plague.
Cenicriviroc, an HIV antiretroviral from the new dual CCR5/CCR2 inhibitor class, performed well in a Phase II trial, but with a high drop-out...
A new entry inhibitor (EI) is in the works.
Tobira Therapeutics is recruiting for a Phase IIb study of its CCR5/CCR2 entry inhibitor cenicriviroc (TBR-652). It is hoped that cenicriviroc...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.